$SBFM's CFO, Camille Sebaaly stated, “We continu
Post# of 21202
(Total Views: 190)
Posted On: 04/05/2021 12:37:53 PM
$SBFM's CFO, Camille Sebaaly stated, “We continue to push ahead with the development of our COVID-19 treatment in collaboration with the University of Georgia and our Adva-27a anticancer compound with our corporate partners in Montreal. This investment is integral to our progress in both of these crucial drug development sectors.”
(0)
(0)Scroll down for more posts ▼